Hepatotoxicity of herbal preparations

Jump to navigation Jump to search

WikiDoc Resources for Hepatotoxicity of herbal preparations

Articles

Most recent articles on Hepatotoxicity of herbal preparations

Most cited articles on Hepatotoxicity of herbal preparations

Review articles on Hepatotoxicity of herbal preparations

Articles on Hepatotoxicity of herbal preparations in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Hepatotoxicity of herbal preparations

Images of Hepatotoxicity of herbal preparations

Photos of Hepatotoxicity of herbal preparations

Podcasts & MP3s on Hepatotoxicity of herbal preparations

Videos on Hepatotoxicity of herbal preparations

Evidence Based Medicine

Cochrane Collaboration on Hepatotoxicity of herbal preparations

Bandolier on Hepatotoxicity of herbal preparations

TRIP on Hepatotoxicity of herbal preparations

Clinical Trials

Ongoing Trials on Hepatotoxicity of herbal preparations at Clinical Trials.gov

Trial results on Hepatotoxicity of herbal preparations

Clinical Trials on Hepatotoxicity of herbal preparations at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Hepatotoxicity of herbal preparations

NICE Guidance on Hepatotoxicity of herbal preparations

NHS PRODIGY Guidance

FDA on Hepatotoxicity of herbal preparations

CDC on Hepatotoxicity of herbal preparations

Books

Books on Hepatotoxicity of herbal preparations

News

Hepatotoxicity of herbal preparations in the news

Be alerted to news on Hepatotoxicity of herbal preparations

News trends on Hepatotoxicity of herbal preparations

Commentary

Blogs on Hepatotoxicity of herbal preparations

Definitions

Definitions of Hepatotoxicity of herbal preparations

Patient Resources / Community

Patient resources on Hepatotoxicity of herbal preparations

Discussion groups on Hepatotoxicity of herbal preparations

Patient Handouts on Hepatotoxicity of herbal preparations

Directions to Hospitals Treating Hepatotoxicity of herbal preparations

Risk calculators and risk factors for Hepatotoxicity of herbal preparations

Healthcare Provider Resources

Symptoms of Hepatotoxicity of herbal preparations

Causes & Risk Factors for Hepatotoxicity of herbal preparations

Diagnostic studies for Hepatotoxicity of herbal preparations

Treatment of Hepatotoxicity of herbal preparations

Continuing Medical Education (CME)

CME Programs on Hepatotoxicity of herbal preparations

International

Hepatotoxicity of herbal preparations en Espanol

Hepatotoxicity of herbal preparations en Francais

Business

Hepatotoxicity of herbal preparations in the Marketplace

Patents on Hepatotoxicity of herbal preparations

Experimental / Informatics

List of terms related to Hepatotoxicity of herbal preparations

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Synonyms and keywords: Synonym 1; Synonym 2; Synonym 3

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Historical Perspective

  • [Disease name] was first discovered by [scientist name], a [nationality + occupation], in [year] during/following [event].
  • In [year], [gene] mutations were first identified in the pathogenesis of [disease name].
  • In [year], the first [discovery] was developed by [scientist] to treat/diagnose [disease name].

Classification

  • [Disease name] may be classified according to [classification method] into [number] subtypes/groups:
  • [group1]
  • [group2]
  • [group3]
  • Other variants of [disease name] include [disease subtype 1], [disease subtype 2], and [disease subtype 3].

Pathophysiology

  • The pathogenesis of [disease name] is characterized by [feature1], [feature2], and [feature3].
  • The [gene name] gene/Mutation in [gene name] has been associated with the development of [disease name], involving the [molecular pathway] pathway.
  • On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
  • On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].

Causes

  • [Disease name] may be caused by either [cause1], [cause2], or [cause3].
  • [Disease name] is caused by a mutation in the [gene1], [gene2], or [gene3] gene[s].
  • There are no established causes for [disease name].

Differentiating [disease name] from other Diseases

  • [Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as:
  • [Differential dx1]
  • [Differential dx2]
  • [Differential dx3]

Epidemiology and Demographics

  • The prevalence of [disease name] is approximately [number or range] per 100,000 individuals worldwide.
  • In [year], the incidence of [disease name] was estimated to be [number or range] cases per 100,000 individuals in [location].

Age

  • Patients of all age groups may develop [disease name].
  • [Disease name] is more commonly observed among patients aged [age range] years old.
  • [Disease name] is more commonly observed among [elderly patients/young patients/children].

Gender

  • [Disease name] affects men and women equally.
  • [Gender 1] are more commonly affected with [disease name] than [gender 2].
  • The [gender 1] to [Gender 2] ratio is approximately [number > 1] to 1.

Race

  • There is no racial predilection for [disease name].
  • [Disease name] usually affects individuals of the [race 1] race.
  • [Race 2] individuals are less likely to develop [disease name].

Risk Factors

  • Common risk factors in the development of [disease name] are [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].

Natural History, Complications and Prognosis

  • The majority of patients with [disease name] remain asymptomatic for [duration/years].
  • Early clinical features include [manifestation 1], [manifestation 2], and [manifestation 3].
  • If left untreated, [#%] of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
  • Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
  • Prognosis is generally [excellent/good/poor], and the [1/5/10­year mortality/survival rate] of patients with [disease name] is approximately [#%].

Diagnosis

Diagnostic Criteria

  • The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met:
  • [criterion 1]
  • [criterion 2]
  • [criterion 3]
  • [criterion 4]

Symptoms

  • [Disease name] is usually asymptomatic.
  • Symptoms of [disease name] may include the following:
  • [symptom 1]
  • [symptom 2]
  • [symptom 3]
  • [symptom 4]
  • [symptom 5]
  • [symptom 6]

Physical Examination

  • Patients with [disease name] usually appear [general appearance].
  • Physical examination may be remarkable for:
  • [finding 1]
  • [finding 2]
  • [finding 3]
  • [finding 4]
  • [finding 5]
  • [finding 6]

Laboratory Findings

  • There are no specific laboratory findings associated with [disease name].
  • A [positive/negative] [test name] is diagnostic of [disease name].
  • An [elevated/reduced] concentration of [serum/blood/urinary/CSF/other] [lab test] is diagnostic of [disease name].
  • Other laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].

Imaging Findings

  • There are no [imaging study] findings associated with [disease name].
  • [Imaging study 1] is the imaging modality of choice for [disease name].
  • On [imaging study 1], [disease name] is characterized by [finding 1], [finding 2], and [finding 3].
  • [Imaging study 2] may demonstrate [finding 1], [finding 2], and [finding 3].

Other Diagnostic Studies

  • [Disease name] may also be diagnosed using [diagnostic study name].
  • Findings on [diagnostic study name] include [finding 1], [finding 2], and [finding 3].

Treatment

Medical Therapy

  • There is no treatment for [disease name]; the mainstay of therapy is supportive care.
  • The mainstay of therapy for [disease name] is [medical therapy 1] and [medical therapy 2].
  • [Medical therapy 1] acts by [mechanism of action 1].
  • Response to [medical therapy 1] can be monitored with [test/physical finding/imaging] every [frequency/duration].

Surgery

  • Surgery is the mainstay of therapy for [disease name].
  • [Surgical procedure] in conjunction with [chemotherapy/radiation] is the most common approach to the treatment of [disease name].
  • [Surgical procedure] can only be performed for patients with [disease stage] [disease name].

Prevention

  • There are no primary preventive measures available for [disease name].
  • Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].
  • Once diagnosed and successfully treated, patients with [disease name] are followed-up every [duration]. Follow-up testing includes [test 1], [test 2], and [test 3].

References